A complete application in a minute
Tailored resume and cover letter, ready to send.
A Universidade de Coimbra, Faculdade de Farmácia, abre uma bolsa de investigação no âmbito do projeto LUPINEGG. O contratado ficará integrado na equipa de pesquisa e desenvolverá atividades ligadas à caracterização de lupin e processos de extracção, sob supervisão de docentes.
A bolsa tem duração inicial de 12 meses, com possibilidade de renovação. O montante mensal é de 1359,64 € e há eventual adesão facultativa à Segurança Social. A candidatura fecha-se 04/11/2026.
Organisation/Company Universidade de Coimbra Research Field Other Researcher Profile First Stage Researcher (R1) Positions Master Positions Application Deadline 4 Nov 2026 - 23:59 (Europe/Lisbon) Country Portugal Type of Contract Temporary Job Status Full-time Hours Per Week 35 Is the job funded through the EU Research Framework Programme? Other EU programme Reference Number 7113 Is the Job related to staff position within a Research Infrastructure? No
Call for Research Grant Assignment
The University of Coimbra opens a call for the assignment of a research grant, with 1 position(s), under the project LUPINEGG - Estudo do Tremoço enquanto Substituto do Ovo e Contratipagem em Doçaria Industrial.The call is governed by this Notice of Opening, the University of Coimbra Research Grant Regulations (RBI-UC), subsidiarily by the Research Grant Regulations of the Foundation for Science and Technology (RBI-FCT), by the Research Fellow Statute (EBI), by the Norms for Grant Assignment and Management within R&D Projects, by the Code of Administrative Procedure (CPA), all in their current wording, and by other applicable national and community legislation.
Procedure Reference: IT137-26-444
Students enrolled in a doctoral programme in the scientific field of Pharmaceutical Sciences, Chemical Sciences, Biological Sciences, Food Science or related fields; OR Master's degree holders in the scientific field of Pharmaceutical Sciences, Chemical Sciences, Biological Sciences, Food Science or related fields, enrolled in a non-degree awarding course.
Candidates enrolled in non-degree-granting courses who have already benefited from a grant contract and who, with this grant assignment, including possible renewals, exceed a total accumulated period of two consecutive or non-consecutive years in this type of grant.
Faculty of Pharmacy, University of Coimbra
Carlos Manuel Freire Cavaleiro, Ana Teresa Sanches Silva, Maria Teresa da Teixeira Cruz Rosete
Development of research work within the scope of the LUPINEGG project, namely:
12 months
Possibily renewable
1359,64€
The grant(s) assigned under this call will be funded by Fundo Europeu de Desenvolvimento Regional (FEDER) through the Regional Programme (CENTRO 2030) of Portugal 2030; reference of operation 21384, operation code CENTRO2030-FEDER-02236100 on Balcão dos Fundos[LM4.1]
All R&D activities directly or indirectly financed by the grant, namely all communications, publications and scientific creations, as well as theses, carried out with the support provided by the grant, must mention the financial support of the Fundo Europeu de Desenvolvimento Regional (FEDER), through the Regional Programme (CENTRO 2030) of Portugal 2030[LM5.1]
Evaluation of the academic record (AR) and/or Interview (I)
- AR: criterion 1 * (30%) + criterion 2 * (50%) + criterion 3 * (10%) + criterion 4 * (10%) = 100%
- I: criterion 1 * (30%) + criterion 2 * (40%) + criterion 3 * (30%) = 100%
- Final Classification (FC): AR * (70%) + I * (30%) = 100%
In the event of a tie in the rankings, candidates will be ordered in descending order as follows:
President: João José Martins Simões Sousa
Effective Members: Carlos Manuel Freire Cavaleiro, Ana Teresa Sanches Silva
Alternate Members: Maria Teresa da Teixeira Cruz Rosete, Artur Manuel Bordalo Machado Figueirinha
the reserve list consists of candidates approved in all selection methods who do not secure one of the available vacancies under this procedure. The reserve list is valid for 6 months
Candidates must access and register on the electronic platform https://apply.uc.pt/ to submit their application, selecting the procedure to which they wish to apply. Documents uploaded for the application must be in portable document format (PDF). Applications are submitted by completing the sections available in the electronic platform "Apply UC" under "My Application."
If the possession of a degree is a requirement for the grant, candidates holding a degree obtained abroad must, by the end of the application period, provide proof of recognition or evidence that it has been requested, as per Decree-Law No. 66/2018 of August 16. Failure to present degree recognition at the time of contract signing, as per the RBI-UC, will result in exclusion.
If duly justified, documents proving the possession of academic degrees and diplomas, or their recognition, may be waived at the application stage and replaced by a candidate's sworn statement. However, until the grant agreement stage, the respective proofs must be submitted under penalty of exclusion.
Proof of enrollment in a degree or non-degree course may be waived at the application stage and replaced by a sworn statement from the candidate. However, the required proof must be submitted by the grant agreement stage under penalty of exclusion.
Whenever possible, documentation proving prior grant benefits should also be attached to the application.
Motivation letter
Any other elements the candidate considers relevant.
When the originals are in another language, a translation into one of these languages must be provided.
The grant does not create or constitute a legal-labor relationship. It is carried out under an exclusive dedication regime, and the grantee is awarded the Research Grantee Status, as stipulated in the EBI and the RBI-UC.
All notifications will be made through the electronic platform Apply UC, under the terms of subparagraph c) of paragraph 1 and subparagraph b) of paragraph 2 of Article 112 of the CPA and Article 22 of the RBI-UC. The notifications will take effect after being made, as provided in Article 113 of the CPA.